| Teva Pharmceuticals USA Inc. | New Jersey | State | 2018 | $39,998,730 | | tax credit/rebate |
| Teva Branded Pharmaceutical Products R&D, Inc. | Pennsylvania | state | 2014 | $6,118,950 | | tax credit/rebate |
| Teva Branded Pharmaceutical Products R&D, Inc. | Pennsylvania | state | 2013 | $5,485,485 | | tax credit/rebate |
| Cephalon, Inc. | Pennsylvania | state | | $4,000,000 | | grant |
| Teva Pharmaceuticals | Kansas | state | 2014 | $3,861,454 | | grant |
| Watson Pharmaceuticals, Inc. and Affiliates | New Jersey | state | 2009 | $3,038,000 | | grant |
| Barr Laboratories, Inc. and Subsidiaries | New Jersey | state | 2002 | $1,969,200 | | grant |
| Cephalon, Inc. | Pennsylvania | state | | $1,749,000 | | tax credit/rebate |
| Cephalon | Utah | state | 2009 | $1,683,200 | | tax credit/rebate |
| Teva Branded Pharmaceutical Products R&D, Inc. | Pennsylvania | state | 2012 | $903,866 | | tax credit/rebate |
| ANDRX Corporation, Inc. | Florida | state | 1998 | $815,500 | | tax credit/rebate |
| Cephalon, Inc. | Pennsylvania | state | 2011 | $740,231 | | tax credit/rebate |
| Watson Pharmaceuticals, Inc. | New Jersey | state | 2011 | $569,910 | | grant |
| Teva Branded Pharmaceutical Products R&D, Inc. | Pennsylvania | state | 2011 | $566,948 | | tax credit/rebate |
| Andrx Corporation, Inc. | Florida | state | 2004 | $525,000 | | tax credit/rebate |
| Barr Laboratories Inc. | Virginia | state | 2008 | $500,000 | | grant |
| Teva Pharmaceuticals USA, Inc. | Pennsylvania | state | | $405,000 | | tax credit/rebate |
| Teva Pharmaceuticals USA, Inc. | Pennsylvania | state | | $400,000 | | grant |
| Barr Laboratories, Inc. | Virginia | state | 2008 | $400,000 | | grant |
| Nupathe, Inc. | Pennsylvania | state | 2008 | $369,626 | | tax credit/rebate |
| Teva Pharmaceuticals USA, Inc. | Pennsylvania | state | | $345,000 | | tax credit/rebate |
| Watson Laboratories, Inc. | Florida | state | 2000 | $312,000 | | tax credit/rebate |
| Watson Pharmaceuticals | New Jersey | state | 2010 | $289,800 | | tax credit/rebate |
| Teva Pharmaceuticals USA, Inc. | Pennsylvania | state | 2010 | $241,071 | | tax credit/rebate |
| Nupathe, Inc. | Pennsylvania | state | 2009 | $206,194 | | tax credit/rebate |
| WATSON LABORATORIES, INC. | California | state | 2003 | $166,452 | | training reimbursement |
| NuPathe, Inc. | Pennsylvania | state | 2011 | $161,044 | | tax credit/rebate |
| TEVA Pharmaceuticals USA | Pennsylvania | state | | $150,000 | | training reimbursement |
| Teva Pharmaceuticals USA, Inc. | Pennsylvania | state | 2009 | $145,313 | | tax credit/rebate |
| Teva Pharmaceuticals USA, Inc. | Pennsylvania | state | 2017 | $137,235 | | tax credit/rebate |
| Teva Pharmaceuticals USA, Inc. | Pennsylvania | state | 2012 | $129,362 | | tax credit/rebate |
| Teva Biopharmaceuticals USA, Inc. | Maryland | state | 2016 | $76,366 | | tax credit/rebate |
| Teva Biopharmaceuticals, Inc. | Maryland | state | 2008 | $76,270 | | tax credit/rebate |
| Nupathe, Inc. | Pennsylvania | state | 2010 | $54,157 | | tax credit/rebate |
| Teva Biopharmaceuticals USA, Inc. | Maryland | state | 2015 | $53,885 | | tax credit/rebate |
| Teva Biopharmaceuticals, Inc. | Maryland | state | 2012 | $50,570 | | tax credit/rebate |
| Teva Biopharmaceuticals, Inc. | Maryland | state | 2014 | $50,570 | | tax credit/rebate |
| Watson Pharmaceuticals | Mississippi | state | 2012 | $50,000 | | training reimbursement |
| Teva Biopharmaceuticals, Inc. | Maryland | state | 2010 | $42,015 | | tax credit/rebate |
| TEVA Biopharmaceuticals, Inc. | Maryland | state | 2009 | $41,319 | | tax credit/rebate |
| Teva Pharmaceuticals | Kansas | local | 2017 | $37,036 | | tax credit/rebate |
| Teva Pharmaceuticals | Kansas | local | 2018 | $36,371 | | tax credit/rebate |
| WATSON PHARMACEUTICALS, INC. | California | state | 2005 | $32,240 | | training reimbursement |
| Teva Pharmaceuticals | Kansas | local | 2016 | $31,654 | | tax credit/rebate |
| Teva Biopharmaceuticals USA, Inc. | Maryland | state | 2017 | $30,972 | | tax credit/rebate |
| TEVA Biopharmaceuticals, Inc. | Maryland | state | 2011 | $26,524 | | tax credit/rebate |
| Ivax Pharmaceuticals | New York | local | 2008 | $13,095 | | tax credit/rebate; property tax abatement |
| NuPathe, Inc. | Pennsylvania | state | 2012 | $12,593 | | tax credit/rebate |
| Teva Pharmaceuticals USA, Inc. | Pennsylvania | state | 2011 | $10,746 | | tax credit/rebate |
| Watson Laboratories, Inc. | Utah | state | 2009 | $7,450 | | training reimbursement |
| IVAX PHARMACEUTICALS | New York | local | 2005 | $5,214 | | tax credit/rebate; property tax abatement |
| Ivax Pharmaceuticals | New York | local | 2007 | $4,930 | | tax credit/rebate; property tax abatement |
| ACTAVIS ELIZABETH LLC | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |
| ACTAVIS ELIZABETH LLC | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |
| Andrx/Anda Pharmaceuticals (Lexington Groveport I LLC & Anda Pharm) | Ohio | local | 2009 | undisclosed | | property tax abatement |
| Andrx/Anda Pharmaceuticals (Lexington Groveport I LLC & Anda Pharm) | Ohio | local | 2010 | undisclosed | | property tax abatement |
| Andrx/Anda Pharmaceuticals | Ohio | local | 2011 | undisclosed | | property tax abatement |
| ANDRX Corporation, Inc. | Florida | state | 2005 | undisclosed | | tax credit/rebate |
| Andrx Pharmaceuticals, Inc. | Florida | state | 2003 | undisclosed | | tax credit/rebate |
| Teva Pharmaceuticals USA, Inc. | Kansas | state | 2016 | undisclosed | | grant |
| Teva Pharmaceuticals USA, Inc. | Kansas | state | 2017 | undisclosed | | grant |
| Teva Pharmaceuticals USA, Inc. | Kansas | state | 2018 | undisclosed | | grant |
. 